Hormone Replacement Therapy
Between 20 and 50% of women from age 45 to 70 have taken or are now taking hormone replacement therapy (HRT) drugs such as Premarin and Prempro. Thousands of women were led to believe that these drugs were safe and provided health benefits.
On July 9, 2002, the National Institutes of Health (NIH) revealed that it was abruptly halting the use of Wyeth’s Prempro in the Women’s Health Initiative (WHI) study because of unacceptable risks associated with taking the drug.
Letters were sent to study participants urging them to stop taking the drug because it led to an increased risk of breast cancer, heart disease and stroke.
Study shows the risks of HRT
The publicly funded study of HRT was intended to assess the benefits of hormone replacement and whether drugs like Prempro and Premarin helped in the prevention of heart disease, breast and colon cancer, and osteoporosis.
Diseases and disorders related to HRT
The WHI study showed that combined HRT (estrogen + progestin) such as Prempro, and some estrogen-only formulations, such as Premarin, increase the risk of the following diseases and disorders:
• Breast cancer • Coronary heart disease
• Ovarian cancer • Scleroderma
• Dementia • Stroke
• Non-Hodgkin’s lymphoma • Blood clots
• Deep vein thrombosis • Pulmonary embolism
Learn the answers to frequently asked questions about hormone replacement therapy.
If you or a family member were prescribed hormone replacement therapy and suffer from breast, ovarian or uterine cancers, stroke, heart disease, lupus or non-Hodgkin’s lymphoma, you may be entitled to compensation. Contact Hissey Kientz today, toll-free, at (866) 275-4454 or fill out a free online case evaluation form to the right of this page.